Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis

por Paul, Sanjoy K, Montvida, Olga, Best, Jennie H, Gale, Sara, Pethö-Schramm, Attila, Sarsour, Khaled
Publicado 2021

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

por Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimón, Bao, Min, Bernasconi, Corrado, Pethö-Schramm, Attila
Publicado 2018

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

por Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimón, Bao, Min, Bernasconi, Corrado, Pethö-Schramm, Attila
Publicado 2018

Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis

por Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimon, Bao, Min, Devenport, Jenny, Pethö-Schramm, Attila
Publicado 2019

Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis

por Curtis, Jeffrey R., Nebesky, Jan Michael, de Bock, Elodie, de la Loge, Christine, Arnould, Benoit, Davey, Robert, Devenport, Jenny, Pethö-Schramm, Attila
Publicado 2021

Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab

por Teitsma, Xavier M., Devenport, Jenny, Jacobs, Johannes W. G., Pethö-Schramm, Attila, Borm, Michelle E. A., Budde, Petra, Bijlsma, Johannes W. J., Lafeber, Floris P. J. G.
Publicado 2020

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotre...

por Teitsma, Xavier M., Jacobs, Johannes W. G., Mokry, Michal, Borm, Michelle E. A., Pethö-Schramm, Attila, van Laar, Jacob M., Bijlsma, Johannes W. J., Lafeber, Floris P. J.
Publicado 2017

Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using...

por Verhoeven, Maxime M. A., Tekstra, Janneke, Jacobs, Johannes W. G., Bijlsma, Johannes W. J., van Laar, Jacob M., Pethö‐Schramm, Attila, Borm, Michelle E. A., Lafeber, Floris P. J., Welsing, Paco M. J.
Publicado 2022

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combin...

por Teitsma, Xavier M, Yang, Wei, Jacobs, Johannes W G, Pethö-Schramm, Attila, Borm, Michelle E A, Harms, Amy C, Hankemeier, Thomas, van Laar, Jacob M, Bijlsma, Johannes W J, Lafeber, Floris P J G
Publicado 2018

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate

por Verhoeven, Maxime M A, Tekstra, Janneke, Welsing, Paco M J, Pethö-Schramm, Attila, Borm, Michelle E A, Bruyn, George A W, Bos, Reinhard, Griep, Ed N, Klaasen, Ruth, van Laar, Jacob M, Lafeber, Floris P J G, Bijlsma, Johannes W J, de Hair, Marjolein J H, Jacobs, Johannes W G
Publicado 2020